| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |